U.S. Software Stock News

NYSE:PRIM
NYSE:PRIMConstruction

Why Did Primoris Services (PRIM) Move Today?

Why Primoris Services Stock Is In Focus After Its Latest Update Primoris Services (PRIM) is back on investor radars after reporting a quarterly net loss alongside a record US$13.9b backlog, while keeping full year earnings guidance intact but trimming free cash flow expectations. See our latest analysis for Primoris Services. The latest results and guidance have come after a sharp reset in sentiment toward Primoris Services, with the 90 day share price return down 27.07% and the year to date...
NYSE:CVSA
NYSE:CVSAConsumer Services

Covista (CVSA) Is Up 10.6% After Raising 2027 Revenue Outlook On Strong Q4 Earnings Results

Covista Inc. reported past fourth-quarter 2026 results showing sales of US$501.38 million and net income of US$71.72 million, with full-year sales of US$1.95 billion and net income of US$251.57 million, alongside higher basic and diluted earnings per share versus the prior year. The company also issued fiscal 2027 revenue guidance of US$2.05–2.09 billion, implying mid-single-digit growth and signaling management’s confidence in demand for its healthcare-focused education programs. We’ll now...
NYSE:PRLB
NYSE:PRLBMachinery

Proto Labs (PRLB) Lifts Outlook As Fair Value Looks Fully Valued

Why Proto Labs Stock Is Back In Focus After Its Latest Earnings Proto Labs (PRLB) is drawing renewed investor attention after its second quarter 2026 earnings, full year outlook update, and an employee stock offering were all announced on 31 July 2026. See our latest analysis for Proto Labs. The strong second quarter update and raised 2026 revenue growth outlook have arrived alongside a sharp shift in sentiment. Proto Labs has posted a 19.5% 1 month share price return and a 92.28% 1 year...
NasdaqGS:AMLX
NasdaqGS:AMLXPharmaceuticals

Is Amylyx (AMLX) Quietly Rewriting Its R&D Risk‑Reward Profile As Losses Deepen Without Revenue?

Amylyx Pharmaceuticals reported Q2 2026 results in August, with a net loss of US$43.42 million compared with US$41.44 million a year earlier, and a six‑month net loss of US$84.71 million versus US$77.35 million, even as basic loss per share from continuing operations narrowed slightly year over year. The combination of a higher absolute net loss and modest per‑share loss improvement highlights the growing cost base behind Amylyx’s development pipeline at a time when it still generates no...
NYSE:TXNM
NYSE:TXNMElectric Utilities

TXNM Energy (TXNM), What Is Behind The Latest Attention?

TXNM Energy earnings event and why it matters for investors TXNM Energy (TXNM) released second quarter 2026 results on July 31, with sales and earnings figures provided for both the quarter and the first half of the year, giving investors fresh data to assess the stock. See our latest analysis for TXNM Energy. At a latest share price of $57.60, TXNM Energy has seen a 1-month share price return of 1.28%, while its 1-year total shareholder return of 3.95% contrasts with a stronger 3-year total...
NasdaqCM:RIOT
NasdaqCM:RIOTSoftware

Riot Platforms (RIOT) Nears Q2 Earnings, Is The Stock 30% Undervalued?

What the Upcoming Q2 2026 Earnings Call Means for Riot Platforms Stock Riot Platforms (RIOT) is set to report its Q2 2026 results on August 10, an event that often refocuses attention on revenue trends, profitability, and how the business mix affects the stock. The company operates as a US based Bitcoin mining and engineering business, with recent annual revenue of US$653.3 million and a reported net loss of US$867.3 million. Investors may watch how those figures evolve when the new numbers...
NYSE:BA
NYSE:BAAerospace & Defense

How Investors May Respond To Boeing (BA) Securing FAA Certification For Its 737-7 MAX

The U.S. Federal Aviation Administration has now granted Boeing an amended type certificate for its new 737-7, completing a multi-year certification program involving more than 1,000 hours of testing and clearing the smallest, longest-range 737 MAX for commercial service and inclusion under Production Certificate No. 700. This approval not only enables deliveries to launch customer Southwest Airlines but also signals a clearer alignment with current regulatory expectations, particularly...
NYSE:FTK
NYSE:FTKChemicals

Flotek Industries (FTK) Raised 2026 Guidance, Is The Stock Fully Priced?

Flotek Industries (FTK) has been in focus after raising its 2026 revenue and EBITDA guidance, supported by record second quarter results and a new 10 year Puerto Rico power project agreement that expanded its contracted backlog. See our latest analysis for Flotek Industries. The latest Puerto Rico contract news and raised 2026 guidance have coincided with strong momentum in Flotek Industries, with the stock posting a 38.58% 1 month share price return and a 155.56% 1 year total shareholder...
NYSE:ITW
NYSE:ITWMachinery

How ITW’s Higher Dividend and New Buyback Plan Has Changed Its Investment Story

Illinois Tool Works Inc. recently announced that its Board approved a 7% increase in the regular annual cash dividend from US$6.44 to US$6.88 per share, effective with a fourth-quarter dividend of US$1.72 payable on October 9, 2026, and also authorized a new share repurchase program of up to US$6.00 billion. Alongside this capital return update, the company reported year-over-year growth in second-quarter sales and earnings and raised its 2026 earnings and revenue guidance, underscoring...
NYSE:SVV
NYSE:SVVMultiline Retail

Savers Value Village (SVV) Jumped, So What Is Behind The Fresh Attention?

Savers Value Village (SVV) has given investors fresh information to assess after reporting second quarter earnings, updating full year guidance, and highlighting early results from its ThriftIQ pricing platform rollout. See our latest analysis for Savers Value Village. The recent earnings, guidance update, ThriftIQ rollout and buyback activity appear to have caught the market's attention, with Savers Value Village recording a 1-day share price return of 12.01% and a 90-day share price return...
NasdaqGS:STOK
NasdaqGS:STOKBiotechs

Is Stoke Therapeutics' (STOK) New Shelf Filing Reframing Its Path Through Mounting Operating Losses?

In August 2026, Stoke Therapeutics reported second‑quarter 2026 results showing sales of US$9.33 million versus US$13.82 million a year earlier, alongside a net loss of US$61.62 million and basic and diluted loss per share of US$0.93 from continuing operations, compared with US$23.48 million and US$0.40 a year ago. For the first half of 2026, sales dropped to US$15.55 million from a very large prior‑year figure, while the company swung from net income of US$89.40 million to a net loss of...